SLDBSolid Biosciences Inc.

$581M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$18M

Net Income

-$18M

EPS (Diluted)

$-7.80

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$20M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$171M

Total Liabilities

$9M

Stockholders' Equity

$162M

Cash & Equivalents

$146M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$18M	-$12M	-52.9%
Net Income	-$18M	-$11M	-59.0%

SLDB Q2 2018 Earnings — Solid Biosciences Inc. Revenue & Financial Results | Market Cap Arena